NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Stable angina pectoris
Date of first enrollment	01/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Nicorandil (SG-75) INN of investigational material : Therapeutic category code : 217 Vasodilators Dosage and Administration for Investigational material : SG-75 group: SG-75 5mg three times a day ISMN group: ISMN 20mg twice daily

Outcome(s)

Primary Outcome	Efficacy: change in time to 1mm ST-segment depression in exercise tolerance test Safety: adverse drug reaction and adverse events
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria	1)males or females older than 18 year-old 2)a history of stable angina pectoris for at least one month ( according to the Guideline for Diagnosis of Angina Pectoris in China) 3)chest pain being relievable by short-acting nitrates 4)willing to provid written informed consent
Exclude criteria